Received Oct 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | RA |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | RA |
Bad headache began within 12 hours of injection; This is a spontaneous report received from a Consumer or other non HCP. A 73-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 19Sep2025 at 15:45 as dose 1, single (Batch/Lot number: unknown) at the age of 73 years, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 19Sep2025 at 15:45 as dose 1, single, in right arm for influenza immunisation. The patient's relevant medical history included: "Drug allergy" (unspecified if ongoing), notes: Nonone. Concomitant medication included: GABAPENTIN, start date: 30Jun2025. The following information was reported: HEADACHE (non-serious) with onset 19Sep2025 at 22:00, outcome "not recovered", described as "Bad headache began within 12 hours of injection". Therapeutic measures were taken as a result of headache. Additional information: The patient experienced a bad headache that began within 12 hours of injection, and it was ongoing at the time of the report. No over-the-counter medications reduced the pain. The vaccine was administered at a pharmacy or drug store. The patient didn't receive any other vaccines within 4 weeks prior the Pfizer vaccine. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Drug allergy (Nonone)
GABAPENTIN